GovChime
Notice ID: a42f4dcc45b24f308155b07e53d3fc57Special Notice

OFF-X (Translational Safety/Toxicology), and its Cortellis Drug Discovery Intelligence with BioMarkers Module software application license subscription

Archived on March 25, 2024. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
12:00 PM UTC−04:00
Posted
March 15, 2024
Notice type
Special Notice
Agency
Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH

Notice details

Office
NATIONAL INSTITUTES OF HEALTH NIDA
Last updated
Sep 9, 2025

Identifiers

Solicitation number
75N95024Q00191
Notice ID
a42f4dcc45b24f308155b07e53d3fc57

Description

See sole source notice attached.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Documents

No documents available.

Lifecycle

Solicitation:75N95024Q00191
  1. Special NoticeCurrentMar 15, 2024

    OFF-X (Translational Safety/Toxicology), and its Cortellis Drug Discovery Intelligence with BioMarkers Module software application license subscription

    Notice a42f4dcc45b24f308155b07e53d3fc57 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline
This Presolicitation notice is NOT a Request for Quotation (RFQ)/Solicitation, however all responsible sources may submit a capability statement, quotation, bid, or proposal, as appropriate, which will be considered by the agency. The Government intends to award a purchase order to Information Management Services on a sole source basis under the authority of RFO FAR 12.102(a) - Restricting competition. Responses shall be submitted electronically to Jacob Balenson via email to jacob.balenson@nih.gov, and Sandra Daniels sandra.daniels@nih.gov no later than November 25, 2026 at 10:00 AM (Eastern Time). Emails must reference Presolicitation Number 75N98027Q00046 in the subject line. See attached Presolicitation Notice and Statement of Work (SOW) for more information.
-Pre-Solicitation11/25/2026
Title: Navajo Area Learning Management System Agency: Indian Health Service Issue Date: Friday, November 6, 2026 Due Date: Friday, November 13, 2026, no later than 12:00pm EST POCs: Responses must be submitted via email to carlton.taylor@hhs.gov. Include “Navajo Area Learning Management System – Your Company Name” in the Subject of the email and complete/return the IEE Representation Form This Sources Sought Notice (SSN) is for market research and planning purposes only and shall not be construed as a solicitation or an obligation or commitment to issue a solicitation by the Indian Health Service (IHS). This SSN is seeking information from the specific types of entities listed below to assess their capabilities in fulfilling the requirements set forth in this SSN. The information from this SSN will be used to determine the appropriate set-aside, if any, in accordance with the applicable regulations listed. The Government encourages the identified to respond to this Notice and will be assessed of their capabilities in the following priority: Indian Small Business Economic Enterprises (ISBEE) Indian Economic Enterprises (IEE) in accordance with HHSAR 326.603-1 Responses to the information requested will assist the Government in determining the appropriate acquisition method, including whether any ISBEE/IEE set-aside is possible based on the Contracting Officer’s reasonable expectation of obtaining offers from two or more relevant concerns that will be competitive in terms of market price, product quality, and delivery capability. An organization that is not considered an ISBEE/IEE firm under the applicable NAICS code should NOT submit a response to this notice. The applicable primary NAICS code for this requirement is 611420 – COMPUTER TRAINING. This is a purchase for a Learning Management System that meets the Federal Government’s FedRAMP compliance, including technical support, maintenance, updates and possible upgrades. Generic capability statements are not sufficient and may not be considered when assessing entity capabilities. Background Indian Health Service is an Agency within the Department of Health and Human Services (HHS). The Indian Health Service (IHS) is the principal federal health care provider and health advocate for Indian people, and its goal is to raise their health status to the highest possible level. IHS provides a comprehensive health service delivery system for approximately 2.3 million American Indians and Alaska Natives (AI/AN) who belong to 573 federally recognized Tribes in 37 states. Navajo Area Indian Health Service (NAIHS) is one of twelve (12) Regional Administrative units of the Indian Health Service (IHS). The NAIHS delivers Health Services to a user population of over 244,000 American Indians in five (5) Federal Service Units on and near the Navajo Nation. The five (5) Federal Service Units (SUs) include Chinle, Crownpoint, Gallup, Kayenta, and Shiprock SUs. Navajo Area Indian Health Service Office is located in St. Michael’s Arizona. This sources sought notice is seeking qualified contractors, to provide a Learning Management System (LMS) Portal. The Learning Management System Portal will supplement the Department of Health and Human Services’ (DHHS) current Learning Management System to provide focused e-learning to meet accreditation requirements (e.g., The Joint Commission (TJC), Centers for Medicare/Medicaid Services (CMS)). The LMS will be available for all staff under NAIHS, including the Navajo Area Office, and the five Federal service units, which include primary hospitals and remote healthcare centers under each service unit. For the current submission and subsequent years, NAIHS is requesting a compliant Learning Management System that meets FedRAMP requirements. This recurring requirement keeps the current service level and licensing active. A complete Statement of Work is attached with the full requirements outlined. Summary Purpose and Objectives The Contractor shall provide a Learning Management System that meets the Federal Government’s FedRAMP compliance. The Learning Management System shall meet 508 compliance and be SCORM compliant. The Learning Management System shall provide focused clinical training courses applicable to accreditation requirements to meet health care accreditation (a) The Joint Commission (TJC) accreditation, (b) The Centers for Medicare/Medicaid Services (CMS) accreditation (c) Other applicable accreditation bodies. The Learning Management System shall provide a learning catalog that includes the following: (a) Safety and Infection Control (b) Advance Cardiac Life Support (ACLS) (c) Advance Trauma Life Support (ATLS) (d) Pediatric Life Support (PALS) (e) S.T.A.B.L.E (f) Neonatal Resuscitation Program (N.R.P.) (g) Other mandatory training courses listed in the attached SOW. The Learning Management System shall include an Authoring tool with the software component, allowing administrators to upload training and curriculum into the LMS. The Learning Management System shall include SCORM program with video storage for interactive course development, allowing administrator to upload training and curriculum into the LMS. The Learning Management System shall include technical support and maintenance, including updates and upgrades. The Learning Management System shall provide for documenting and tracking employee attendance, course completion checklists, and generating other reports that help the program and its users. The end users estimate around 5,000 Navajo Area IHS employees; this includes at least 1,000 contractors, volunteers, and tribal employees who work in Navajo Area Healthcare facilities. Additional details in the attached SOW. Capability Statement/Submission Information A response to this SSN will be in the form of a capability statement to demonstrate capability and experience in the task areas identified further below. Specifically, please provide the following information below to demonstrate capabilities: Cover Page Please provide a cover page to include: Company Name Company Designation (ISBEE/IEE/SB) Type of Business – as applicable (e.g. 8(a), Woman Owned Small Business, HUBZone, etc.) UEI Number Point of contact, email address, and phone number Primary NAICS Code(s) Existing federal contracting vehicle(s) numbers, as applicable (e.g. GSA MAS number, NITAAC/CIO SP3, other Government Wide Agency Contracts, etc.) System for Award Management (SAM) registration status. Note, all respondents must be registered on the SAM located at http://www.sam.gov/ prior to any potential award. Executive Summary Provide a high-level overview of your services and include how it will benefit the Indian Health Service. Technical Areas Respondents are expected to submit a capability statement detailing and demonstrating their expertise and technical capabilities in the areas outlined further below in this SSN. Please see attached Statement of Work for full requirements. Past Performance Please provide any past performance information to support demonstration of your capabilities in the relevant technical areas and magnitude of work. Other Information (Optional) You may include any other information that may be helpful in developing or finalizing the requirements of the potential acquisition. Submission Format To assist the Government in an expeditious review of your capabilities, the capability statement should be organized as follows: Cover page Executive Summary Technical Areas in the order listed Indian Health Service Buy Indian Act Indian Economic Enterprise Representation Form Other Information, as applicable The tailored capability statement should not exceed 10 pages excluding Past Performance information. Font must not be less than 10 point (for readability) and may be submitted in either in either Microsoft Word or Adobe Portable Document Format (PDF) but must be a standard 8-1/2 by 11 inch in paper size. All proprietary information should be marked as such. Generic capability statements are not sufficient and will not be considered compliant with the requirements of this notice. Disclaimer and Important Notes This notice does not obligate the Government to award contract. Any information provided by industry to the Government as a result of this SSN is strictly voluntary. Responses will not be returned. No entitlements to payment of direct or indirect costs or charges to the Government will arise as a result of contractor submission of responses or the Government's use of such information. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization’s capabilities to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or received, a pre-solicitation synopsis and solicitation may be published on a government GPE. However, responses to this Notice will not be considered adequate responses to any resultant solicitation. Confidentiality: No classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).
-Market Research11/13/2026
NOTICE OF INTENT (NOI) – Typefi Orion Cloud Teams Software Licenses and Implementation Product Service Code (PSC): 7A21 NAICS Code: 541519 Place of Performance: Online software access supporting CDC, Atlanta, GA 30329-4018 Solicitation Number: 75D301-27-Q-79332 Description This is a Notice of Intent, not a separate request for quote. The Government’s solicitation for this requirement is provided through the associated combined synopsis/solicitation. The Department of Health and Human Services, Office of Mission Acquisition Solutions (OMAS), on behalf of the Centers for Disease Control and Prevention (CDC), National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of the Director (OD), intends to award a firm-fixed-price contract to Typefi Systems, Inc. for Typefi Orion Cloud Teams software licenses, implementation services, and support. The purpose of this requirement is to replace the Emerging Infectious Diseases (EID) journal’s legacy eXtyles editorial-production software and support its manuscript editing, reference validation, metadata preparation, and publication-production workflows. According to Typefi’s November 3, 2026 sole-source letter, eXtyles has been discontinued by its owner, John Wiley & Sons (Wiley). The requirement includes 12 Typefi Orion Cloud Teams user licenses, onboarding and implementation services, a Wiley royalty, training, and technical support. Required capabilities include Orion for Word/Server integration; SmartReplace for automated editorial cleanup; SmartReference for reference validation, correction, and duplicate-reference checking; Harvard-to-Vancouver citation conversion; PubMed and CrossRef deposit capabilities; and JATS XML export. These capabilities support preparation of author-created Microsoft Word documents for publication, including application of editorial styles, automated rule-based edits, validation of references and citations, and production of structured XML for EID’s publishing workflow. The anticipated base period of performance is November 18, 2026, through November 17, 2027. The requirement also includes four annual subscription option periods, exercisable at the Government’s discretion. Justification for Single Source Typefi Systems, Inc. is the proposed single source for Typefi Orion licenses, implementation services, and support. The requirement supports migration from EID’s legacy eXtyles editorial-production software while preserving compatibility with existing editorial configurations and publishing requirements. In its November 3, 2026 sole-source letter, Typefi Systems, Inc. states that the Typefi group of companies developed Orion and owns its intellectual property. Typefi Systems, Inc. holds the exclusive license to sell Orion in the Americas. The letter further states that no unaffiliated reseller, distributor, or other third party is authorized to sell Orion. Typefi also states that Orion is the only solution authorized by Wiley to import existing eXtyles data and configurations, including Auto-Redact dictionaries, article types, metadata, paragraph styles, and citation settings. Typefi holds an exclusive license from Wiley for the eXtyles source code. Orion integrates with Typefi’s Edifix reference-processing service to format, correct, and link references against CrossRef and PubMed. According to Typefi, Edifix uses the same reference-processing engine that powered eXtyles, supporting consistency during migration. Edifix itself is available to other products through a third-party application programming interface and is not asserted to be exclusive to Orion. The proposed acquisition addresses EID’s requirement for the combined editorial automation, authorized migration, reference-processing, and JATS XML export capabilities described above. Authority This acquisition is being conducted under Federal Acquisition Regulation (FAR) Part 12, Acquisition of Commercial Products and Commercial Services, including FAR 12.102(a), as implemented by applicable HHS FAR Overhaul deviations. For acquisitions valued at or below the Simplified Acquisition Threshold, the Contracting Officer must document the decision that only one source is available and the basis for that decision. Submission of Capability Statements Interested parties capable of providing the same or similar products or services must submit a capability statement electronically. Responses will be considered solely for the purpose of determining whether to conduct a competitive procurement. A determination by the Government not to compete the proposed contract, based upon responses to this notice, is solely within the discretion of the Government. Capability statements must demonstrate the ability to provide Typefi Orion Cloud Teams licenses and associated services or an equivalent solution capable of meeting the Government’s editorial-production requirements. Responses must address support for 12 users; Microsoft Word/Server integration; automated editorial cleanup; reference validation, correction, and duplicate-reference checking; Harvard-to-Vancouver citation conversion; PubMed and CrossRef deposit capabilities; and JATS XML export. Capability statements must also explain the proposed approach to migrating existing eXtyles data and configurations, maintaining compatibility with EID’s editorial-production workflow, and providing implementation, training, and ongoing technical support. Respondents proposing Typefi Orion must provide evidence of authorization to supply the required licenses and services. This procurement is subject to FAR 52.232-18 Availability of Funds (APR 1984) Funds are not presently available for this contract. The Government’s obligation under this contract is contingent upon the availability of appropriated funds from which payment for contract purposes can be made. No legal liability on the part of the Government for any payment may arise until funds are made available to the Contracting Officer for this contract and until the Contractor receives notice of such availability, to be confirmed in writing by the Contracting Officer. Deadline: November 12, 2026, at 1:00 PM ET Submit to: Vera Nordalm Contract Specialist Office of Mission Acquisition Solutions (OMAS) Email: vera.nordalm@hhs.gov Copy: Em’Ria Briscoe Contracting Officer Office of Mission Acquisition Solutions (OMAS) Email: EmRia.Briscoe@hhs.gov
-Special Notice11/12/2026
This is a Notice of Intent, not a separate request for quote. The Government’s solicitation for this requirement is provided through the associated combined synopsis/solicitation. The Department of Health and Human Services, Office of Mission Acquisition Solutions (OMAS), on behalf of the Centers for Disease Control and Prevention (CDC), National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of the Director (OD), intends to award a firm-fixed-price contract to Typefi Systems, Inc. for Typefi Orion Cloud Teams software licenses, implementation services, and support. The purpose of this requirement is to replace the Emerging Infectious Diseases (EID) journal’s legacy eXtyles editorial-production software and support its manuscript editing, reference validation, metadata preparation, and publication-production workflows. According to Typefi’s November 3, 2026 sole-source letter, eXtyles has been discontinued by its owner, John Wiley & Sons (Wiley). The requirement includes 12 Typefi Orion Cloud Teams user licenses, onboarding and implementation services, a Wiley royalty, training, and technical support. Required capabilities include Orion for Word/Server integration; SmartReplace for automated editorial cleanup; SmartReference for reference validation, correction, and duplicate-reference checking; Harvard-to-Vancouver citation conversion; PubMed and CrossRef deposit capabilities; and JATS XML export. These capabilities support preparation of author-created Microsoft Word documents for publication, including application of editorial styles, automated rule-based edits, validation of references and citations, and production of structured XML for EID’s publishing workflow. The anticipated base period of performance is November 18, 2026, through November 17, 2027. The requirement also includes four annual subscription option periods, exercisable at the Government’s discretion. Justification for Single Source Typefi Systems, Inc. is the proposed single source for Typefi Orion licenses, implementation services, and support. The requirement supports migration from EID’s legacy eXtyles editorial-production software while preserving compatibility with existing editorial configurations and publishing requirements. In its November 3, 2026 sole-source letter, Typefi Systems, Inc. states that the Typefi group of companies developed Orion and owns its intellectual property. Typefi Systems, Inc. holds the exclusive license to sell Orion in the Americas. The letter further states that no unaffiliated reseller, distributor, or other third party is authorized to sell Orion. Typefi also states that Orion is the only solution authorized by Wiley to import existing eXtyles data and configurations, including Auto-Redact dictionaries, article types, metadata, paragraph styles, and citation settings. Typefi holds an exclusive license from Wiley for the eXtyles source code. Orion integrates with Typefi’s Edifix reference-processing service to format, correct, and link references against CrossRef and PubMed. According to Typefi, Edifix uses the same reference-processing engine that powered eXtyles, supporting consistency during migration. Edifix itself is available to other products through a third-party application programming interface and is not asserted to be exclusive to Orion. The proposed acquisition addresses EID’s requirement for the combined editorial automation, authorized migration, reference-processing, and JATS XML export capabilities described above. Authority This acquisition is being conducted under Federal Acquisition Regulation (FAR) Part 12, Acquisition of Commercial Products and Commercial Services, including FAR 12.102(a), as implemented by applicable HHS FAR Overhaul deviations. For acquisitions valued at or below the Simplified Acquisition Threshold, the Contracting Officer must document the decision that only one source is available and the basis for that decision. Submission of Capability Statements Interested parties capable of providing the same or similar products or services must submit a capability statement electronically. Responses will be considered solely for the purpose of determining whether to conduct a competitive procurement. A determination by the Government not to compete the proposed contract, based upon responses to this notice, is solely within the discretion of the Government. Capability statements must demonstrate the ability to provide Typefi Orion Cloud Teams licenses and associated services or an equivalent solution capable of meeting the Government’s editorial-production requirements. Responses must address support for 12 users; Microsoft Word/Server integration; automated editorial cleanup; reference validation, correction, and duplicate-reference checking; Harvard-to-Vancouver citation conversion; PubMed and CrossRef deposit capabilities; and JATS XML export. Capability statements must also explain the proposed approach to migrating existing eXtyles data and configurations, maintaining compatibility with EID’s editorial-production workflow, and providing implementation, training, and ongoing technical support. Respondents proposing Typefi Orion must provide evidence of authorization to supply the required licenses and services. Deadline: November 12, 2026, at 1:00 PM ET Submit to: Vera Nordalm Contract Specialist Office of Mission Acquisition Solutions (OMAS) Email: vera.nordalm@hhs.gov Copy: Em’Ria Briscoe Contracting Officer Office of Mission Acquisition Solutions (OMAS) Email: EmRia.Briscoe@hhs.gov
-Combined Synopsis11/12/2026
Synopsis: This is a Small Business Sources Sought notice. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding: (1) the availability and capability of qualified small business sources to perform a potential requirement; (2) whether they are small businesses; 8(a) small businesses, service-disabled veteran-owned small businesses; veteran-owned small businesses; women-owned small businesses; HUBZone small businesses; or small disadvantaged businesses; and (3) their size classification relative to the North American Industry Classification system (NAICS) code for the potential acquisition. Your responses to the information requested will assist the government in determining the appropriate acquisition method, including whether a small business set aside is possible. An organization that is not considered a small business under the applicable NAICS code should not submit a response to this notice. The requirement is assigned a code of 541715 in the North American Industry Classification System (NAICS), and the small business size standard for such requirements is 1,000 employees or less. This notice is issued for market research purposes to assess potential small business sources, industry practices, and the availability of commercial services. The Government has not made a final determination regarding acquisition strategy, contract type, commerciality, or small business set-aside status. Respondents should identify whether they can perform the requirement as a prime contractor, including through existing teaming arrangements or qualified subcontractors, and distinguish their own capabilities from those of proposed team members. Background: The National Institute on Minority Health and Health Disparities (NIMHD) conducts and supports research and training programs to advance knowledge and understanding of health disparities, identify mechanisms to improve minority health and reduce health disparities, and develop effective interventions in community and clinical settings. NIMHD is the lead organization at the National Institutes of Health (NIH) for planning, reviewing, coordinating, and evaluating minority health and health disparities research activities. NIMHD also promotes workforce development, supports research capacity at less-resourced institutions that train students in research careers, serves populations experiencing health disparities, supports participation in clinical research, and promotes information dissemination through regular communications, public education outreach, and scientific presentations. The President’s Executive Order (EO) 14212 Establishing the President’s Make America Healthy Again Commission aims to improve the health of Americans. As described in the EO, escalating burden of chronic diseases poses significant challenges in the United States. These conditions contribute to rising health costs, reduced workforce productivity, and stagnant life expectancies across the country, both in adults and children. NIH defines a health disparity as a measurable difference in health that exists between specific population groups. This is a rigorously derived and data-driven determination operationalized by quantifiable metrics, rather than a statement of attribution. It is a scientific starting point that identifies where health outcomes diverge, not a predetermined conclusion about why. Scientific investigations to identify or understand the root causes are separate and distinct scientific questions, which are necessarily multifaceted and complex. NIH funded research is interested in those health disparities that are modifiable or actionable to improve the health of all population groups. Health disparities may be observed in the risks, prevalence, or problems resulting from specific behaviors, as well as the incidence, prevalence, and mortality from conditions, diseases, and/or disorders. To fulfill the NIH mission of seeking fundamental knowledge about the nature and behaviors of individuals as living systems, and the statutory purpose of NIMHD, to conduct research to understand and reduce health disparities, NIMHD Division of Intramural Research (DIR) conducts population health research to understand how health outcomes vary across populations, identify multilevel modifiable factors that drive these disparities, and develop, test, and evaluate clinical and population-based interventions to reduce these disparities. NIMHD DIR requires contractor assistance to provide R&D social and behavioral sciences research services to support NIMHD DIR in conducting population health and clinical research to understand and reduce health disparities in the United States. The Government anticipates that individual task orders may involve differing research designs, study populations, sites, durations, and levels of complexity. Interested firms should explain their ability to mobilize qualified personnel and research resources for multiple concurrent studies as requirements arise. NIMHD is seeking small businesses capable of designing, conducting and overseeing the clinical, scientific, and technical aspects of investigations into health disparities across populations, to identify modifiable risk and protective factors associated with these disparities, and develop and test interventions to reduce these disparities. Study designs to be used may include, but are not limited to: Population-based cross-sectional surveys; Epidemiological studies (e.g., longitudinal cohort study, case-control studies); Clinical trials; Community-based intervention studies; Simulation modeling; and Qualitative research methods (e.g., direct observations, in-depth interviews, focus groups discussions). Independently and not as an agent of the Government, the Contractor shall furnish all necessary services, qualified personnel, material, equipment, and facilities not otherwise provided by the Government to successfully perform the requirements stated below. Specifically, the Contractor shall, as required by individual task orders, perform the following technical requirements summarized below that also are included in the attached Draft Statement of Work (SOW), including but not limited to: Provide personnel, facilities, and other services necessary to maintain and coordinate multiple health disparities research studies funded through task orders under this Indefinite Delivery, Indefinite Quantity (IDIQ) contract. Provide overall project management and coordination of activities performed under individual task orders, including development and maintenance of project plans, schedules, milestones, coordination of participating research sites and subcontractors, monitoring of performance, identification and resolution of project risks and issues, and preparation of progress reports as specified in the applicable task order. Conduct research studies through qualified organizations, as specified in individual task orders, and receiving consent from the Contracting Officer’s Representative (COR) and Contracting Officer (CO). This includes (but is not limited to) implementation of protocols; population health and clinical research site monitoring; regulatory compliance assurance; and analyses of data from clinical, laboratory, population and epidemiologic studies. Provide and manage participating population health research and clinical trial sites, investigators, laboratories, and other research resources necessary to conduct studies, directly or through qualified subcontractors. The Contractor shall draft, negotiate, execute, administer, monitor, renew and/or modify as necessary, subject to subcontractor's satisfactory past performance, and with the consent of the CO, subcontracts with domestic population health studies, clinical research sites and laboratories, and provide support for these population health studies, clinical research site and laboratories. The Contractor shall assume responsibility for population health and clinical sites, including site readiness to start new research studies. This includes the establishment of new subcontract agreements for these sites (including laboratories), data management, and other operations and functions. As existing protocols close, the Contractor shall assume responsibility for any new protocols at these sites. Recruit and retain numbers of potential research subjects sufficient for the timely completion of all protocols. Provide United States based investigators in the United States with expertise in the population health and clinical care, to conduct protocols specified through individual task orders. Provide professional and technical staff adequate to provide scientific and administrative coordination of multiple population health and clinical health disparities research studies. These staff shall include, but are not limited to, qualified medical, nursing, and neuropsychologic staff, study coordinators, personnel for participant identification, recruitment, study conduct, and retention, pharmacists, and laboratory technicians. Ensure sites have access to populations of interest, laboratory facilities with the capability to perform clinical research specified in task orders. Identify and engage community organizations, community leaders, health care providers, and other relevant stakeholders; establish and support community advisory boards, community coalitions, or other partnerships; conduct community needs and readiness assessments; and facilitate community participation in research planning, implementation, and dissemination of findings. Develop and implement quantitative and qualitative data collection methods, including surveys, interviews, focus groups, direct observations, and other methods appropriate to the research protocol. The Contractor shall manage, analyze, and report data collected through these methods, as required by individual task orders. Provide facilities and equipment adequate to conduct population health, inpatient and outpatient clinical research studies. Equipment purchases must be approved by the COR and CO. Ensure that sites have (through lease or direct provision, if required) electronic information systems compliant with the Federal Information Security Modernization Act (FISMA), necessary specialized equipment (including hardware and software) for sites to electronically communicate with the Contractor, subcontractors, and NIMHD DIR as required, for processing and storage of biospecimens (e.g., ultralow temperature freezer, specialized shipping materials and training for shipment of biohazardous materials and dangerous goods, and for receipt, storage, monitoring, and dispensing of investigational drugs). Obtain access for research protocol review and approval (or exemption) to a standing Institutional Review Board (IRB) and ensure that each institution conducting population health and clinical research studies has a current, approved Federal-Wide Assurance Number on file with the Office for Human Research Protections (OHRP). Ensure that all the staff at each site participating in the design or conduct of population health and clinical research involving human subjects, complete and maintain education on the human research protections. Ensure that when appropriate, population health and clinical research sites have a community advisory board (CAB) constituted with members of the local community that can provide community perspective and advice for science in the community where the population health and clinical research is located and that provides community input. The Contractor shall provide services to ensure regulatory compliance for research activities including subcontracted sites' performance. More specifically: Ensure site access to a communications system in compliance with U.S. Food and Drug Administration (FDA) requirements for the submission of Adverse Experience Reports (AERs) by Subcontractors to the Contractor for transmission as required to the COR as required. Monitor the accuracy of adverse experience reporting through regular summary reports for submission to the COR. Draft safety reports as required by the FDA for selected studies for COR Submission. Develop, implement, and monitor plans for acquisition, distribution, dispensing, handling, administration, and accountability of study interventions (pharmaceutical and non-pharmaceutical), in compliance with applicable Federal, state, and local regulations. Provide site monitoring for quality assurance of research conducted at all clinical and laboratory sites, as designated by the COR. Monitoring schedules shall be approved by and results reported to the COR with a copy to the CO and shall include assurance of compliance with FDA record keeping and reporting requirements (21 CFR 50 and 56; 21 CFR 312.50, Subpart D), accuracy and completeness of case report forms, source documentation, and other research records, and periodic record auditing and documentation by the staff of the subcontracted centers. Each site shall be visited a minimum of 2-3 times annually. Provide staff with laboratory expertise and assist in monitoring clinical trials site laboratory quality with the COR and NIMHD Quality Assurance (QA) programs. Meet with the NIMHD program and contracting staff to review annual site performance and monitoring reports for participating population health and clinical research sites. The Contractor shall provide population health, clinical and statistical analysis and reports. More specifically: Provide scientific, technical, and administrative support for the development, implementation, and analysis of the specified research, including considerations of experimental design, sample size calculation, and interim and final primary and secondary analyses specified by study protocols, as requested by the COR. Establish data elements to be recorded by the protocol research records, as requested by the COR and in conjunction with the protocol development team for each specific research project. Develop study forms for standardized collection of data items. Develop documentation and coding for computerization of data for retrieval, analysis, and reporting. Provide for timely and accurate data collection and submission, data entry, data quality assurance, retrieval of source documentation, and generation of data and safety monitoring reports. Provide training for staff of population health, clinical and laboratory sites in data management procedures. Provide data input, editing, electronic data storage, database management, data retrieval, and statistical analysis using well-documented database management and statistical computer software programs. Develop methodology, perform analyses, and provide results from meta-analyses of selected data sets derived from population health and clinical research studies that focus on health disparities. Provide data analysis and results. More specifically: Perform statistical analyses of study data to test study hypotheses and evaluate potential confounding variables and/or covariates, as requested by the COR. Data analytic techniques needed include approaches to analyzing multiple measurements of biologic variables over time within participants and between participant groups, with consideration for normal changes in these variables with demographics. Provide for biweekly to monthly communication, as needed, of analytic progress and results through routine meetings (the majority to be virtually) with COR or designees and periodic generation of reports. The Project Manager shall attend all meetings. The Epidemiologist, Statistician, and Senior Systems Analyst shall attend these meetings on an as needed basis dependent upon the PI’s request. Provide programming and statistical support adequate for the timely generation of additional analyses requested by the COR. Provide electronic data transmission between the Contractor, population health, clinical and laboratory sites, and NIMHD DIR using currently specified communications software and equipment. Provide for electronic mail transmission between the Contractor, population health, clinical and laboratory sites, and NIMHD DIR using commercially available communications software and equipment. Provide protocol development services and assistance. The Contractor shall provide services for the implementation and monitoring of multiple population health and clinical research studies. More specifically: Develop, initiate and coordinate implementation and oversight of protocols at all participating population health, clinical and laboratory sites designed by the COR and approved by the CO. Ensure compliance by sites with all requirements for protocol implementation, including IRB review and approval prior to protocol initiation, participant consent, and confidentiality requirements, and Federal bioresearch regulations and requirements for security and confidentiality of research records, and that each relevant population health and clinical research site staff member completes and maintains human research protection and Good Clinical Practice training, when appropriate. Draft, negotiate, execute, administer, monitor, renew and/or modify as necessary with approval by CO a site-specific, protocol-specific budget for each protocol to be conducted by population health, clinical and laboratory sites, based on the anticipated number of participants to be enrolled. Provide training for staff of clinical and laboratory centers in procedures for implementation and conduct of specific protocols. Retraining may be required to be performed as necessary. Provide training in and ensure the fulfillment and maintenance of standards for Good Clinical Practices (GCP) and Good Clinical Laboratory Practices (GCLP) across population health and clinical research sites and staff, whenever appropriate. Ensure timely development and execution of material transfer agreements (MTAs) and data transfer agreements (DTAs) between the sponsor(s) and population health and clinical research sites. The Contractor shall provide services for the development and review of research activities. More specifically: For specific new protocol topics identified by the COR, identify a protocol development team consisting of Contractor staff, NIH staff, subcontractors, and/or consultants. Provide support for the planning and conduct of protocol development team meetings. Submit at the initial meeting a protocol development plan for COR review and approval, addressing regulatory issues, data collection forms development, drug distribution plan, protocol timeline, and participating sites. Develop a protocol document including background, objectives and endpoints, design, patient numbers, source, management, and selection, study agents or other interventions, clinical and laboratory monitoring, laboratory services, toxicity management, adverse experience reporting, evaluation of response, statistical considerations, data collection and monitoring, human subjects’ considerations, biohazard containment, and data and safety reviews. Review, edit, and rewrite draft protocols based on COR’s review. Prepare and maintain the necessary documentation for application submissions in compliance with FDA requirements. Upon completion of a final protocol, renegotiate subcontractor budgets with the approval of the CO and implement the new protocol at participating sites. For ongoing protocols, provide, at the request of the COR, support for the planning and conduct of meetings of protocol committees and subcommittees, data and safety monitoring boards, and investigators. Provide administrative, technical, and logistical support at the request of the COR and with approval of the CO as needed for interaction and collaboration of the Subcontractors with other institutes, agencies, and organizations conducting activities relevant to health disparities research. Support the identification, development, implementation, and evaluation of interventions to improve health outcomes and reduce health disparities, including assessment of feasibility, acceptability, effectiveness, and potential impact. Provide consultants with specialized expertise related to population health and clinical research especially related to health disparities, as requested by NIMHD DIR. Plan, organize, and coordinate meetings involving internal and outside experts. This meeting will be an important venue to discuss important and complex scientific issues related to research protocols and emerging research priorities. Provide support services for ongoing population health and clinical research studies, which include, but are not limited to, the following: site monitoring, subcontract management and invoicing, protocol management, oversight of data management and data analysis, study agent procurement, team meetings, regulatory compliance assurance, site activation and protocol registration, safety monitoring, committee management, data management services, oversight of central and site laboratories and pharmacies, protocol team support, FISMA compliance and IT security, laboratory equipment support, and training of site personnel, to support this effort. Provide Core infrastructure support for ongoing population health and clinical research at the sites, including but not limited to the following: maintenance of IRB/EC regulatory reporting, subject recruitment and follow-up, Community Advisory Board (CAB) support for meetings, protocol updates and reporting, attendance and participation in site monitoring visits, attendance at the annual network meeting, invoicing and other report preparation. Experience coordinating data from all aspects of ongoing protocols, studies, and trials. Experience in initiating and managing 3-6 studies each year. Experience initiating and managing studies of different sizes from approximately 100 participants up to approximately 10,000 participants. Experience working with populations experiencing health disparities, e.g., people in low socioeconomic conditions, living in rural underserved areas, and racial and/or ethnic populations who have documented health disparities based on diseases and conditions. Experience initiating and managing studies with a length in time from a few months for cross-sectional studies to a few years in clinical studies. Experience managing studies of varying complexities from simpler studies, which may be qualitative studies involving in-depth interviews with about 100 people; to more complex studies that involve a multi-site clinical trial with 1-2 years follow-up including biospecimen collection. Commercial Availability of Services – Based on preliminary market research, the Government anticipates that the contemplated research services may be noncommercial in nature. However, interested respondents are encouraged to identify comparable services available in the commercial marketplace. If so, describe which portions of the requirement could be met commercially and which would require customization, integration, or specialized development. Provide supporting information, including customary pricing practices and potential firm-fixed-price arrangements, if available. Industry Feedback on Draft SOW – Respondents are encouraged to provide comments or recommendations on the draft SOW, including opportunities to clarify requirements, improve performance outcomes, identify potential implementation challenges, or incorporate commercially available approaches. Identify any provisions that may unnecessarily limit small business participation and suggest practical alternatives. Any recommendations should identify the applicable SOW section when possible. Anticipated Award Date: The Government expects to award an Indefinite Delivery Indefinite Quantity (IDIQ) contract approximately in September 2027. Disclaimer and Important Notes: This notice does not obligate the government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization’s qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a presolicitation synopsis and solicitation may be published in SAM.gov. However, responses to this notice will not be considered adequate responses to a solicitation. No award will be made as a result of this notice. The Government will NOT be responsible for any costs incurred by the respondents to this Notice. This notice is for information purposes only. CONFIDENTIALITY: No proprietary, classified, confidential, or sensitive information should be included in your response. The government reserves the right to use any nonproprietary technical information in any resultant solicitation(s). Responses and Capability Statements: Interested Small Businesses that believe they possess the capabilities necessary to undertake this project should submit an electronic copy of their capability statement addressing the areas listed above to the attention of Edwin Osorio, Contract Specialist (E-mail: edwin.osorio@nih.gov) and Lisa Schaupp, Contracting Officer (E-mail: lisa.schaupp@nih.gov). Please state clearly in the subject line of the email that it is in response to the Sources Sought notice no.75N94027R00005. Please limit responses to 20 pages or less, exclusive of resumes. Electronic capability statements should be received by the Contracting Officer and Contract Specialist by 4:30 PM Eastern time on November 25, 2026. Respondents must submit their capability statement via electronic submission only. Capability statements must identify the 1) organization name, address, point of contact, contact phone number, and email address; 2) Small Business status of the organization, NAICS code along with SAM.gov Unique Entity Identifier (UEI) and CAGE code, if assigned, size and type of business (e.g., 8(a), HUBZone, etc.). No phone calls will be accepted. The designated NAICS code for this effort is 541715 and the size standard is 1,000 employees or less. Respondents may provide brief SOW comments and commercial availability information within the existing 20-page response limit. The Government may use the information received to refine the draft SOW and acquisition strategy; participation does not preclude responding to any future solicitation.
-Market Research11/25/2026

Additional Details

Solicitation Number

75N95024Q00191

Archive Date

Mar 25, 2024

Office Address

Bethesda, MD, 20892